COVID-19 and off label use of drugs: an ethical viewpoint.

Published in: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2020)

There are different types of approaches, none of them is comprehensive and conclusive. Furthermore, respecting the four ethical principles necessitates codification and strict regulation of off-label uses either as clinical practice or investigational. Besides, compilation of a special guideline based on ethical principles especially non-maleficence and autonomy for investigational off-label uses in disasters is highly recommended.

Keyphrases

clinical practice
coronavirus disease
decision making
sars cov
phase ii
clinical trial
randomized controlled trial
drug induced
respiratory syndrome coronavirus